Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial

作者：Chunmei Bai, Yi Zheng, Meili Sun, Jieer Ying, Fuxiang Zhou, Yiyi Yu, Ligang Xing, Yanqiao Zhang, Jinhua Wen, Heshui Wu, Xiuli Yang, Lixin Wan, Shiwei Guo, Rusen Zhao, Zhizhen Zhu, Wei Shen, Qi Wang, Shanzhi Gu, Hao Wu, Weichang Chen, Jin Xia, Jun Zhao, Xiaofang Dong, Wenhui Lou, Kuirong Jiang, Zhiye Zhang, Xiaobing Chen, Deliang Fu, Youshan Chen, Baoqing Wang, Jiaxin Liu, Yuan Ji, Shijie Yuan, Yuan Li, Zhihua Gong, Fei Da, Xia Qin, Crystal Qin, Jin Li · 发表于：European Journal of Cancer · 年份：2025 · DOI：10.1016/j.ejca.2025.115808 · 被引用次数：11 · 研究领域：Barrier Structure and Function Studies、HER2/EGFR in Cancer Research、Pancreatic and Hepatic Oncology Research